Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia

Cancer. 2014 Feb 1;120(3):452. doi: 10.1002/cncr.28442. Epub 2013 Oct 22.

Authors

Paolo Strati¹, Susan O'Brien

Affiliation

¹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

PMID: 24151154
DOI: 10.1002/cncr.28442

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Female
Humans
Immune Tolerance / drug effects*
Immunotherapy / adverse effects*
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Male
Pancytopenia / chemically induced*